Home › Funds › Palo Alto Investors LP › NBIX
Palo Alto Investors LP position in NBIX
NEUROCRINE BIOSCIENCES INC · Health Care
Palo Alto Investors LP reported holding 18,117 shares of NBIX (NEUROCRINE BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$2.6M, representing 0.38% of its reported portfolio and ranking #34 among its reported holdings. Palo Alto Investors LP has disclosed NBIX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Palo Alto Investors LP's NBIX position evolved
Palo Alto Investors LP first disclosed a stake in NBIX in Q1 2025 at 13,334 shares (US$1.5M). The position peaked in Q2 2026 at 18,117 shares, worth US$3.1M. Across 7 filings, Palo Alto Investors LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 18,117 shares valued at US$2.6M. Notable position changes include a 36% increase in Q3 2025 (shares rose 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 13.33K | $1.47M | New |
| Q2 2025 | 13.33K | $1.68M | Hold |
| Q3 2025 | 18.12K | $2.54M | Add |
| Q4 2025 | 18.12K | $2.57M | Hold |
| Q1 2026 | 18.12K | $2.39M | Hold |
| Q2 2026 | 18.12K | $3.05M | Hold |
| Q3 2026 | 18.12K | $2.57M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NBIX and 13F data
NBIX (NEUROCRINE BIOSCIENCES INC) is a Health Care company. 28 other funds we track also report a position in NBIX — the largest reported positions include Vestal Point Capital, LP (US$354.6M), Renaissance Technologies (US$326.3M), RTW INVESTMENTS, LP (US$133.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NBIX
- Vestal Point Capital, LP 2.50M sh · $354.60M · Q3 2026
- Renaissance Technologies 2.30M sh · $326.33M · Q3 2026
- RTW INVESTMENTS, LP 942.68K sh · $133.71M · Q3 2026
More on Palo Alto Investors LP
FAQ
How long has Palo Alto Investors LP held NBIX?
Palo Alto Investors LP has disclosed NBIX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Palo Alto Investors LP's current position in NBIX?
As of Q3 2026, Palo Alto Investors LP holds 18.12K shares of NBIX (NEUROCRINE BIOSCIENCES INC), valued at $2.57M, representing 0.38% of its reported portfolio and ranking #34.
Has Palo Alto Investors LP been buying or selling NBIX?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP held unchanged its position in NBIX. The position peaked in Q2 2026 at 18.12K shares.
Which other funds hold NBIX?
Other major institutional holders of NBIX include Vestal Point Capital, LP, Renaissance Technologies, RTW INVESTMENTS, LP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.